Hypoparathyroidism Hp In Adults clinical trials

Explore recruiting hypoparathyroidism hp in adults clinical trials.

Also recruiting in Europe

Hypoparathyroidism Hp In Adults trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PaTH Forward: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Trial with an Open-Label Extension, Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Subcutaneously Daily in Adults with Hypoparathyroidism

Denmark, Germany, Norway, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Hypoparathyroidism Hp In Adults trials by city

Hypoparathyroidism Hp In Adults in Toronto Hypoparathyroidism Hp In Adults in Vancouver Hypoparathyroidism Hp In Adults in Montreal Hypoparathyroidism Hp In Adults in Calgary Hypoparathyroidism Hp In Adults in Edmonton Hypoparathyroidism Hp In Adults in Ottawa Hypoparathyroidism Hp In Adults in Winnipeg Hypoparathyroidism Hp In Adults in Quebec City Hypoparathyroidism Hp In Adults in Hamilton Hypoparathyroidism Hp In Adults in Kitchener Hypoparathyroidism Hp In Adults in London Hypoparathyroidism Hp In Adults in Halifax Hypoparathyroidism Hp In Adults in New York Hypoparathyroidism Hp In Adults in Los Angeles Hypoparathyroidism Hp In Adults in Chicago Hypoparathyroidism Hp In Adults in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease